Hollis-Eden (HEPH) and company in the development of a new class of small molecule compounds based on endogenous steroid hormones, today announced new preclinical data with its drug candidate HE3235 for the treatment of…
Stent sales for Boston Scientific (BSX) and Johnson & Johnson (JNJ) have taken a big drop since research began to emerge that the products could cause heart problems. There have been several conflicting studies…
Trimeris Inc. (NASDAQ:TRMS) is feeling a little after-hour pressure. Roche and Trimeris today provided an update on their combined efforts to offer a needle-free device which has been investigated for use with FUZEON® (enfuvirtide).…
Metabasis Therapeutics (NASDAQ:MBRX) announced after the close today that its MB07133 has been granted orphan medicinal product status for the treatment of hepatocellular carcinoma (primary liver cancer) by the European Commission. This designation would…
The Nigerian government is suing Pfizer (PFE) claiming that it "deceived patients and caused the death of 11 children in 1996 when it performed clinical trials for a new drug." According to the government,…
A Canadian court ruled that Apotex could not market a generic version of Viagra, Pfizer’s (PFE) massively successful ED drug. Oddly, Pfizer’s shares were down 1.2% to $24.35. The Big Pharma company has watched…
SIGA Technologies, Inc. (NASDAQ: SIGA) shares are trading higher after the company announced that its lead smallpox drug, ST-246, has passed another milestone by demonstrating 100% protection against death in cynomolgus monkeys showing signs…
Cephalon Inc. (NASDAQ:CEPH) is a biotech that has been under a bit of a low ceiling after its recent blunder regarding FENTORA. As a reminder FENTORA is that cancer pain drug that the company…
Sonus Pharmaceuticals (SNUS) said that its drug candidate Tocosol Paclitaxel failed in a late-stage study aimed at treating breast cancer, according to AP. The company was trashed by investors, who moved it down 85%…
EMPHASYS MEDICAL, INC. has filed to come public via an initial public offering and has listed it initial sale of securities as up to $86.25 million for filing purposes. The underwriting group includes Morgan…
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has announced preliminary findings from a Phase II study with intramuscular injection of Peramivir, the Company’s product candidate for the treatment of seasonal and life-threatening influenza. It states that…
MAKO Surgical Corp. has filed to come public in an initial public offering and for nominal filing purposes, it lists that it will sell up to $86.25 million in securities. MAKO is taking the…
The Grocery Manufacturers Association is going to ask the government to strengthen regulation of food imports. The group, which includes Kraft (KFT) and Coca-Cola (KO) wants "beef up federal oversight of imported food and…
The Chinese are now poisoning their own population. With any luck, a new case of tainted drugs found in the big Asian country will not make it to the US. But, don’t count on…
ISIS Pharmaceuticals Inc. (NASDAQ:ISIS) is trading up pre-market on new that it entered a broad collaboration with Ortho-McNeil, a Johnson & Johnson (NYSE:JNJ) unit, for discovery, development and commercialization of antisense drugs to treat…